Exploration of the regulatory effect of miR-21 on breast cancer cell line proliferation and invasion as well as the downstream target genes  by Kuang, Ying & Nie, Ying-Jie
HOSTED BY Contents lists available at ScienceDirect
Asian Paciﬁc Journal of Tropical Medicine 2016; 9(5): 470–473470Asian Paciﬁc Journal of Tropical Medicine
journal homepage: http://ees.elsevier.com/apjtmOriginal research http://dx.doi.org/10.1016/j.apjtm.2016.03.025*Corresponding author: Ying-Jie Nie, Associate Chief Technician, Central Lab,
Guizhou Provincial People's Hospital, China.
Tel: +86 13885033479
E-mail: nienyj@hotmail.com
Peer review under responsibility of Hainan Medical College.
Foundation project: This study was supported by National Natural Science
Foundation of China (Grant No.: 81560269).
1995-7645/Copyright © 2016 Hainan Medical College. Production and hosting by Elsevier B.V. This is an open access a
creativecommons.org/licenses/by-nc-nd/4.0/).Exploration of the regulatory effect of miR-21 on breast cancer cell line proliferation and invasion as
well as the downstream target genesYing Kuang, Ying-Jie Nie*Central Lab, Guizhou Provincial People's Hospital, Guiyang City, Guizhou Province, 550000, ChinaARTICLE INFO
Article history:
Received 15 Jan 2016
Received in revised form16 Feb 2016
Accepted 15 Mar 2016
Available online 23 Mar 2016
Keywords:
Breast cancer
MicroRNA
Proliferation
InvasionABSTRACT
Objective: To study the regulatory effects of miR-21 on breast cancer cell line prolif-
eration and invasion as well as the downstream target genes.
Methods: Breast cancer cell lines MCF-7 were cultured and transfected with miR-21
mimics and the corresponding negative control mimics (NC mimics), and then MTS
kits were used to detect cell viability. Transwell experiment was used to detect cell in-
vasion ability, and ﬂuorescence quantitative PCR was used to detect the expression of
proliferation and invasion-related genes in cells.
Results: 24 h after transfection of miR-21 mimics and NC mimics, cell OD value and the
number of invasive cells of miR-21 group were signiﬁcantly higher than those of NC
group, and mRNA contents of PDCD-4, FasL, PTEN, RhoB, Maspin, TIMP3 and RECK
in cells were signiﬁcantly lower than those of NC group.
Conclusion: miR-21 can promote the proliferation and invasion of breast cancer cell
lines, and its downstream target genes include PDCD-4, FasL, PTEN, RhoB, Maspin,
TIMP3 and RECK.1. Introduction
Breast cancer is malignant tumor with highest morbidity in
women and also the main cause of cancer death in women. In
recent years, both morbidity and mortality of breast cancer are
showing a rising trend. Breast cancer is derived from the
mammary epithelial cells, the prognosis of the disease is
related to the abnormal expression of cell proliferation and
invasion-related genes, and the stronger the cell proliferation
and invasion ability, the worse the prognosis of tumor. At
present, the upstream molecular mechanism regulating the
expression of breast cancer cell proliferation and invasion-
related genes is not yet clear [1,2]. Micro RNA (miRNA) is
the single-stranded small RNA that has received more and
more attention in recent years, and it can induce mRNA
degradation or inhibit mRNA translation at posttranscriptional
level, thus achieving the regulation of the expression of a
variety of target genes. In a variety of miRNAs, miR-21 isconﬁrmed to have antitumor effect and is associated with the
pathogenesis of solid malignant tumors such as breast cancer,
stomach cancer and colon cancer [3–5]. This study aims to
clarify the relationship between miR-21 and the occurrence
and progression of breast cancer and to identify its regulating
effects on the biological behavior of breast cancer cells, breast
cancer cell lines were used as research tools to speciﬁcally
analyze the regulating effects of miR-21 on breast cancer cell
line proliferation and invasion as well as the expression of
downstream target genes.
2. Materials and methods
2.1. Experimental materials
Human breast cancer cell lines MCF-7 were purchased from
the cell bank of Chinese Academy of Sciences in Shanghai,
DMEM, fetal bovine serum and trypsin for cell culture were
purchased from Gibco company. MiR-21 mimics and the cor-
responding negative control mimics (NC mimics) were synthe-
sized by Shanghai GenePharma company; MTS cell viability
detection kits were purchased from Promega company. Trans-
fection reagents Lipofectamine 2000 and RNA extraction kits
Trizol were purchased from Invitrogen company. Primers forrticle under the CC BY-NC-ND license (http://
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Sangon company, and PCR kits were purchased from Beijing
Tiangen company.
2.2. Cell culture and transfection
MCF-7 cells were recovered, cultured with DMEM con-
taining 5% fetal bovine serum until cell density reached 70%–
80%, and then digested and ampliﬁed with 0.125% trypsin,
ampliﬁed cells were divided into two, one was inoculated in
culture bottle, continued to be cultured and used for subsequent
digestion and ampliﬁcation, and the other was inoculated in
culture plate, continued to be cultured and used for subsequent
transfection. For cell transfection, miR-21 mimics or NC mimics
were mixed with Lipofectamine 2000 according to the propor-
tion of 1:1, let stand at room temperature for 20 min, then added
to the culture wells of cell plate, continued to be cultured for
24 h and used for subsequent detection.
2.3. Cell viability detection
For cell viability detection, cells were inoculated in 96-well
cell culture plate and transfected for 24 h, then 20 mL MTS
detection solution was added to the culture system for 4 h of
continuous incubation, culture plate was placed in microplate
reader and the absorbance (OD value) at 490 nm wave length
was detected.
2.4. Cell invasion detection
For cell invasion detection, cells were inoculated in Trans-
well chambers and transfected for 24 h, then cell membrane at
the bottom of the chambers was taken out, stained with DAPI
dye and were observed under ﬂuorescence microscope, and the
number of cells within 3 high-power ﬁelds was counted.
2.5. mRNA contents detection
For detection of mRNA contents in cells, cells were inocu-
lated in 12-well cell culture plate and transfected for 24 h, cul-
ture medium was discarded, cells were washed with PBS twice.
Then Trizol lysate was added, total RNA was extracted, 1 mg
RNA was collected for reverse transcription, obtained cDNATable 1
Effect of transfection of miR-21 mimics on proliferation-related gene expres
PDCD-4/b-actin FasL/b
miR-21 group 0.384 ± 0.074 0.504 ±
NC group 1.000 ± 0.081 1.000 ±
t 11.216 5.042
P <0.05 <0.05
Table 2
Effect of transfection of miR-21 mimics on invasion-related gene expression
Maspin/b-actin
miR-21 group 0.663 ± 0.105
NC group 1.000 ± 0.110
t 4.426
P <0.05was ampliﬁed according to the following procedure: 95 C and
10 s, speciﬁc annealing temperature and 20 s, 72 C and 30 s,
repeating for 40 cycles, and after ampliﬁcation curves and take-
off cycle number Ct were obtained, mRNA contents were
calculated according to 2−DDCt.
2.6. Statistical methods
Data were analyzed with SPSS20.0 software, and comparison
between two groups was conducted by t test and differences
were considered to be statistically signiﬁcant at a level of
P < 0.05.
3. Results
3.1. Cell viability
24 h after transfection of miR-21 mimics and NC mimics,
cell OD value of miR-21 group was 0.980 ± 0.101 which was
signiﬁcantly higher than 0.561 ± 0.077 of the NC group showing
signiﬁcant differences between two groups (P < 0.05).
3.2. Cell invasion
24 h after transfection of miR-21 mimics and NC mimics, the
number of invasive cells of miR-21 group was (131.00 ± 19.54)
which was signiﬁcant higher than (71.25 ± 8.34) of NC group,
and difference between two groups was statistically signiﬁcant
(P < 0.05).
3.3. Proliferation-related gene expression
24 h after transfection of miR-21 mimics and NC mimics,
mRNA contents of PDCD-4, FasL, PTEN and RhoB in cells of
miR-21 group were signiﬁcantly lower than those of NC group
(Table 1).
3.4. Invasion-related gene expression
24 h after transfection of miR-21 mimics and NC mimics,
mRNA contents of Maspin, TIMP3 and RECK in cells of miR-
21 group were signiﬁcantly lower than those of NC group
(Table 2).sion.
-actin PTEN/b-actin RhoB/b-actin
0.102 0.306 ± 0.043 0.559 ± 0.059
0.168 1.000 ± 0.138 1.000 ± 0.114
9.626 6.844
<0.05 <0.05
.
TIMP3/b-actin RECK/b-actin
0.461 ± 0.065 0.334 ± 0.079
1.000 ± 0.098 1.000 ± 0.129
9.146 8.817
<0.05 <0.05
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MicroRNAs is a type of non-coding small RNA, and the
length of mature miRNA is about 18–24 bp. Primary transcript
Pri-miRNA becomes mature miRNA by the hydrolysis of
Drosha, Dicer and other enzymes, then is assembled into RNA-
induced silencing complex (RISC) and combined with mRNA
30 non-translated region in the form of complementary base
pairing to induce mRNA degradation or inhibit mRNA trans-
lation, thus achieving the posttranscriptional regulation of gene
expression [6,7]. The pathogenesis of breast cancer is associated
with the abnormal expression of multiple genes, but upstream
molecules regulating gene expression are unclear. MicroRNA
is involved in the regulation of more than 50% of genes in
the body by means of posttranscriptional regulation, and
miR-21 is conﬁrmed to be related to the occurrence, metas-
tasis and poor prognosis of tumor. A number of studies have
shown that miR-21 expression in breast cancer tissue is
signiﬁcantly higher than that in normal breast tissue suggesting
that miR-21 has the function of oncogene in the development
process of cancer [8–10].
In the occurrence and development process of breast cancer,
the strong proliferation ability and invasive ability of cancer
cells are the key links causing local tumor growth and distant
metastasis. In this study, the in vitro cultured breast cancer cell
lines were chosen as research tools, transfection of miR-21
mimics was adopted to simulate high miR-21 expression
state in breast cancer tissue, and then cell proliferation and
invasion ability were evaluated. Analysis of the detection re-
sults of cell vitality by MTS showed that OD value of the cells
of miR-21 group was signiﬁcantly higher than that of NC
group; analysis of the detection results of cell invasion by
transwell showed that the number of invasive cells of miR-21
group was signiﬁcantly higher than that of NC group sug-
gesting that miR-21 played a promoting role in breast cancer
cell proliferation and invasion, and high expression of miR-21
in breast cancer tissue could increase the cell vitality and
promote invasive growth of cells.
The main way for miRNA to play its role is to be combined
with mRNA 30 non-translated region, and its effect is to cause
mRNA degradation or inhibit mRNA transcription. In the
occurrence and development process of breast cancer, a variety
of molecules are involved in regulating cell proliferation and
invasion, and there are miR-21 binding sites in mRNA 30 non-
translated region of a variety of proliferation and invasion-
related molecules. PDCD-4, FasL, PTEN and RhoB gene-
encoded molecules are closely related to the regulation of
breast cancer cell proliferation, and Maspin, TIMP3 and RECK
gene-encoded molecules are closely related to the regulation of
breast cancer cell invasion. Studies have reported that miR-21
can target and regulate PDCD-4, FasL, PTEN, RhoB, Maspin,
TIMP3, RECK and other proliferation and invasion-related
genes in bladder cancer, stomach cancer, esophageal cancer
and other malignant tumor cells [11–15]. However, it has not been
reported whether miR-21 regulates the above expression of
proliferation and invasion-related genes in breast cancer cells.
PDCD-4, FasL, PTEN and RhoB are tumor suppressor genes,
and their expression signiﬁcantly reduces in breast cancer, lung
cancer and other malignant tumors. Fatty acid synthase ligand
(FasL) belongs to the tumor necrosis factor receptor super
family, is cell apoptosis signal receptor, and can be combined
with Fas to induce cell apoptosis and activate cellular immunityto kill target cells [16]; programmed cell death receptor 4
(PDCD4) is a kind of tumor suppressor gene, and the protein
expressed by it is located in the nucleus and can inhibit cell
proliferation and promote cell apoptosis through Sp-
transcription factors; PTEN-encoded protein contains 4 cyclic
structures of amino acid residue insertion sequence, which can
induce cell cycle arrest and apoptosis through PI3K/Akt
pathway [17]. After transfection of miR-21 mimics, mRNA
contents of proliferation-related molecules PDCD-4, FasL,
PTEN and RhoB in breast cancer cell lines decreased signiﬁ-
cantly. This meant that miR-21 could target and regulate
proliferation-related molecules PDCD-4, FasL, PTEN and RhoB
in breast cancer cells.
Maspin, TIMP3 and RECK are genes with invasion-
inhibiting effect, and they show a trend of low expression in
breast cancer and lung cancer, which will cause enhanced cancer
cell invasion ability. Maspin belongs to the serpin super family,
and is a kind of secretory protein that can block the combination
of uPA with receptor uPAR to inhibit cell invasion [18]. RECK-
encoded protein contains three serine hydrolase inhibitors re-
gions, has inhibitory effect on the secretion and activity of
several kinds of MMPs, and can prevent MMP2 and MMP9
degradation of extracellular matrix [19]; tissue inhibitor of
metalloproteinase TIMPs can directly combine with MMPs
and suppress their function, blocking the degradation of
extracellular matrix [20]. After transfection of miR-21 mimics,
mRNA contents of invasion-related molecules Maspin, TIMP3
and RECK in breast cancer cell lines decreased signiﬁcantly.
This meant that miR-21 could target and regulate invasion-
related molecules Maspin, TIMP3 and RECK in breast cancer
cells.
To sum up, miR-21 can promote the proliferation and inva-
sion of breast cancer cell lines, and its downstream target genes
include PDCD-4, FasL, PTEN, RhoB, Maspin, TIMP3 and
RECK.
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